Gout and risk of myocardial infarction: A systematic review and meta-analysis of cohort studies

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Liu, Shuang Chun ^a   Xia, Lei ^b   Zhang, Jin ^a   Lu, Xue Hong ^a   Hu, Da Kang ^a   Zhang, Hai Tao ^a   Li, Hai Jun ^a  

^a TAIZHOU MUNICIPAL HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; COHORT ANALYSIS; DISEASE ASSOCIATION; GOUT; HEART INFARCTION; HUMAN; ONSET AGE; REVIEW; SYSTEMATIC REVIEW; ADULT; AGED; COMPLICATION; META ANALYSIS; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; COHORT STUDIES; GOUT; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; YOUNG ADULT;

EID: 84941956401     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134088     Document Type: Review

References (57)

1. WHO. (Updated May 2014) World Health Organization: the 10 leading causes of death by broad income group. Available: http://www. Who. Int/mediacentre/factsheets/fs310/en/[Accessed July 2015]
2. WHO. (2008) The global burden of disease: 2004 update. Geneva, Switzerland: WHO.
3. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. (2013) Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 127:e6-e245. doi: 10.1161/CIR.0b013e31828124ad PMID: 23239837
4. Xu J, Kochanek KD, Murphy SL, Tejada-Vera B. (2010) Deaths: final data for 2007. Natl Vital Stat Rep 58:1-19.
5. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al. (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 67:960-966. PMID: 17981913
6. Bardin T., Bouée S., Clerson P., Chalès G., Doherty M., Flipo R.-M., et al. (2014) SAT0544 Prevalence of Gout in the Adult Population of France in 2013. Ann Rheum Dis 73:787-788
7. Zhu Y, Pandya BJ, Choi HK. (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 63:3136-3141. doi: 10.1002/art.30520 PMID: 21800283
8. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29:2403-2406. PMID: 12415600
9. Roddy E, Zhang W, Doherty M. (2007) The changing epidemiology of gout. Nat Clin Pract Rheumatol 3:443-449. PMID: 17664951
10. Weaver AL. (2008) Epidemiology of gout. Cleve Clin J Med 75:S9-12. PMID: 18819329
11. Libby P, Theroux P. (2005) Pathophysiology of coronary artery disease. Circulation 111:3481-3488. PMID: 15983262
12. Tiong AY, Brieger D. (2005) Inflammation and coronary artery disease. Am Heart J 150:11-18. PMID: 16084145
13. Krishnan E, Baker JF, Furst DE, Schumacher HR. (2006) Gout and the risk of acute myocardial infarction. Arthritis Rheum. 54:2688-2696. PMID: 16871533
14. Choi HK, Curhan G. (2007) Independent impact of gout on mortality and risk for coronary heart disease. Circulation 116:894-900. PMID: 17698728
15. De Vera MA, Rahman MM, Bhole V, Kopec JA, Choi HK. (2010) Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann Rheum Dis 69:1162-1164. doi: 10.1136/ard.2009.122770 PMID: 20124358
16. Kuo CF, Yu KH, See LC, Chou IJ, Ko YS, Chang HC, et al. (2013) Risk of myocardial infarction among patients with gout: a nationwide population-based study. Rheumatology (Oxford) 52:111-117.
17. Seminog OO, Goldacre MJ. (2013) Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies. Rheumatology (Oxford) 52:2251-2259.
18. So A. (2010) Epidemiology: Gout-bad for the heart as well as the joint. Nat Rev Rheumatol 6:386-387. doi: 10.1038/nrrheum.2010.78 PMID: 20596050
19. Zhu Y, Pandya BJ, Choi HK. (2012) Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med 125:679-687.e1. doi: 10.1016/j.amjmed.2011.09.033 PMID: 22626509
20. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008-2012. PMID: 10789670
21. G A Wells, B Shea, D O'Connell, J Peterson, V Welch, M Losos, et al. (2013) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available: www.ohri.ca/programs/clinical-epidemiology/oxford.asp. [Accessed July 2015]
22. Begg CB, Mazumdar M. (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics. 50:1088-1101. PMID: 7786990
23. DerSimonian R, Laird N. (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-88. PMID: 3802833
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG. (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560. PMID: 12958120
25. Dalbeth N, Haskard DO. (2005) Mechanisms of inflammation in gout. Rheumatology (Oxford) 44:1090-1096.
26. Tiong AY, Brieger D. (2005) Inflammation and coronary artery disease. Am Heart J 150:11-18. PMID: 16084145
27. Pascual E. (1991) Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout. Arthritis Rheum 34:141-145. PMID: 1994910
28. Dalbeth N, Haskard DO. (2005) Mechanisms of inflammation in gout. Rheumatology (Oxford) 44:1090-1096.
29. Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH. (2008) Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 168:1104-1110. doi: 10.1001/archinte.168.10. 1104 PMID: 18504339
30. Busso N, So A. (2010) Mechanisms of inflammation in gout. Arthritis Res Ther 12:206. doi: 10.1186/ar2952 PMID: 20441605
31. Edwards NL. (2008) The role of hyperuricemia and gout in kidney and cardiovascular disease. Cleve Clin J Med 75:S13-16.
32. Ballocca F, D'Ascenzo F, Moretti C, Omedè P, Cerrato E, Barbero U, et al. (2014) Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and metaanalysis. Eur J Prev Cardiol [Epub ahead of print]
33. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183-1190. PMID: 12707287
34. Becker MA, Jolly M. (2006) Hyperuricemia and associated diseases. Rheum Dis Clin North Am 32:275-93, v-vi. PMID: 16716880
35. Halligan C; Matteson EL. (2005) Hyperuricemia and coronary artery disease. Current Rheumatology Reviews 1:193-197.
36. Brodov Y, Behar S, Boyko V, Chouraqui P. (2010) Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study). Am J Cardiol 106:1717-1720. doi: 10.1016/j.amjcard.2010.07.046 PMID: 21126615
37. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. (2010) Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 62:170-180.
38. Fang J, Alderman MH. (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283:2404-2410. PMID: 10815083
39. Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, et al. (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164:1546-1551. PMID: 15277287
40. Freedman DS, Williamson DF, Gunter EW, Byers T. (1995) Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 141:637-644. PMID: 7702038
41. Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P. (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 36:1072-1078. PMID: 11116127
42. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST. (1995) Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am J Epidemiol 142:288-294. PMID: 7631632
43. Feig DI, Kang DH, Johnson RJ. (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811-1121. doi: 10.1056/NEJMra0800885 PMID: 18946066
44. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, et al. (2001) Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38:1101-1106. PMID: 11711505
45. Sánchez-Lozada LG, Tapia E, Avila-Casado C, Soto V, Franco M, Santamaría J, et al. (2002) Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 283:F1105-1110. PMID: 12372787
46. Sánchez-Lozada LG, Tapia E, Santamaría J, Avila-Casado C, Soto V, Nepomuceno T, et al. (2005) Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 67:237-247. PMID: 15610247
47. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. (2002) Circulation 105:1135-1143. PMID: 11877368
48. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41:1287-1293. PMID: 12743010
49. Netea MG Kullberg BJ, Blok WL, Netea RT, van der Meer JW. (1997) The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood 89:577-582. PMID: 9002961
50. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, et al. (2001) Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38:1101-1106. PMID: 11711505
51. Kanellis J, Kang DH. (2005) Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 25:39-42. PMID: 15660333
52. Gersch C, Palii SP, Kim KM, Angerhofer A, Johnson RJ, Henderson GN. Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids 27:967-978. doi: 10.1080/15257770802257952 PMID: 18696365
53. Gür M, Sahin DY, Elbasan Z, Kalkan GY, Yildiz A, Kaya Z, et al. (2013) Uric acid and high sensitive Creactive protein are associated with subclinical thoracic aortic atherosclerosis. J Cardiol 61:144-148. doi: 10.1016/j.jjcc.2012.08.023 PMID: 23159203
54. Clarson LE, Chandratre P, Hider SL, Belcher J, Heneghan C, Roddy E, et al. (2015) Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis. Eur J Prev Cardiol 22:335-343. doi: 10.1177/2047487313514895 PMID: 24281251
55. Kuo CF, See LC, Luo SF, Ko YS, Lin YS, Hwang JS, et al. (2010) Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology (Oxford) 49:141-146.
56. Puig JG, Michán AD, Jiménez ML, Pérez de Ayala C, Mateos F. (1991) Female gout. Clinical spectrum and uric acid metabolism. Arch Intern Med 151:726-732. PMID: 2012455
57. Hartling L, Milne A, Hamm MP, Vandermeer B, Ansari M, Tsertsvadze A, et al. (2013) Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers. J Clin Epidemiol 66:982-993. doi: 10.1016/j.jclinepi.2013.03.003 PMID: 23683848